KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Deferred Taxes: 2009-2025

Historic Deferred Taxes for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $93.2 million.

  • Idexx Laboratories' Deferred Taxes rose 1461.48% to $93.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.4 million, marking a year-over-year increase of 267.16%. This contributed to the annual value of -$24.2 million for FY2024, which is 49.92% up from last year.
  • As of Q3 2025, Idexx Laboratories' Deferred Taxes stood at $93.2 million, which was up 3,661.52% from $2.5 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Deferred Taxes high stood at $93.2 million for Q3 2025, and its period low was -$33.6 million during Q4 2023.
  • Moreover, its 3-year median value for Deferred Taxes was -$2.6 million (2024), whereas its average is $2.5 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first plummeted by 9,186.81% in 2022, then spiked by 1,461.48% in 2025.
  • Idexx Laboratories' Deferred Taxes (Quarterly) stood at -$7.4 million in 2021, then soared by 124.58% to $1.8 million in 2022, then slumped by 1,938.74% to -$33.6 million in 2023, then skyrocketed by 113.93% to $4.7 million in 2024, then spiked by 1,461.48% to $93.2 million in 2025.
  • Its last three reported values are $93.2 million in Q3 2025, $2.5 million for Q2 2025, and $3.9 million during Q1 2025.